Vaccine alliance says 300,000 doses of Merck's Ebola shot available for emergencies

LONDON (Reuters) - The GAVI global vaccine alliance said on Friday some 300,000 emergency doses of an Ebola vaccine developed by Merck could be available in case of a large-scale outbreak, after the World Health Organization confirmed a fatal case in Congo.